SMTL ID : 5jzb.1

Crystal structure of HsaD bound to 3,5-dichlorobenzene sulphonamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

homo-tetramer

Ligands

4 x 6OT: 3,5-dichlorobenzene-1-sulfonamide(Non-covalent)

6OT.1: 12 residues within 4Å: Chain A: G.39, G.40, Y.70, S.108, L.109, G.134, L.152, F.167, M.202, V.237, N.238, H.263 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.109, A:L.152 Hydrogen bonds: A:N.238, A:N.238 Water bridges: A:G.135 6OT.3: 13 residues within 4Å: Chain B: G.39, G.40, Y.70, S.108, L.109, G.134, L.152, F.167, M.202, F.206, V.237, N.238, H.263 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:L.109, B:L.152 Hydrogen bonds: B:N.238, B:N.238 6OT.4: 12 residues within 4Å: Chain C: G.39, G.40, Y.70, S.108, L.109, G.134, L.152, F.167, M.202, V.237, N.238, H.263 5 PLIP interactions: 5 interactions with chain C Hydrophobic interactions: C:L.109, C:L.152 Hydrogen bonds: C:N.238, C:N.238 Water bridges: C:G.135 6OT.6: 13 residues within 4Å: Chain D: G.39, G.40, Y.70, S.108, L.109, G.134, L.152, F.167, M.202, F.206, V.237, N.238, H.263 4 PLIP interactions: 4 interactions with chain D Hydrophobic interactions: D:L.109, D:L.152 Hydrogen bonds: D:N.238, D:N.238

2 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.2: 6 residues within 4Å: Chain A: E.147, R.151, R.169, V.170, K.175 Chain B: K.150 7 PLIP interactions: 6 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:E.147 Water bridges: A:K.175, A:K.175 Salt bridges: A:R.151, A:R.169, A:K.175, B:K.150 PO4.5: 6 residues within 4Å: Chain C: E.147, R.151, R.169, V.170, K.175 Chain D: K.150 7 PLIP interactions: 6 interactions with chain C, 1 interactions with chain D Hydrogen bonds: C:E.147 Water bridges: C:K.175, C:K.175 Salt bridges: C:R.151, C:R.169, C:K.175, D:K.150

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ryan, A. et al., Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach. Br. J. Pharmacol. (2017)

Release Date

2017-04-05

Peptides

4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase